GlaxoSmithKline's expenditure on research and development by sector 2015-2021
This statistic shows the adjusted expenditure of pharmaceutical company GlaxoSmithKline on research and development, from 2015 to 2021. In 2021, the company spent around 3.6 billion GBP on research and development within its pharmaceuticals segment. GlaxoSmithKline plc is a global pharmaceutical and biotech company, headquartered in London.